Beta Drugs (NSE:BETA) Dividends per Share: ₹0.00 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BETA Beta Drugs Ltd NSE:BETA
94 GF Score
Price ₹2,229.10
GF Value ₹1,982.44
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Beta Drugs Dividends per Share?

Beta Drugs NSE:BETA -1.40% 94 Dividends per Share is ₹0.00 as of Mar. 2026. GuruFocus rates NSE:BETA with a GF Score™ of 94/100 and a GF Value™ of ₹1,982.44 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Beta Drugs's dividends per share for the three months ended in Mar. 2026 was ₹0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00. As of today, Beta Drugs's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Beta Drugs  (NSE:BETA) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Beta Drugs's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0/ 8.93
=0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Drugs Dividends per Share Related Terms

Beta Drugs Dividends per Share Historical Data

* Premium members only.

The historical data trend for Beta Drugs's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Drugs Dividends per Share Chart

Beta Drugs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Beta Drugs Quarterly Data
Mar17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:BETA vs ZTS, UTHR: Dividends per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Beta Drugs's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beta Drugs Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beta Drugs's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Beta Drugs's Dividend Yield % falls into.


NSE:BETA
94GF Score
Beta Drugs Ltd NSE:BETA
Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beta Drugs Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of ₹0.00 mean?
Beta Drugs (NSE:BETA) has a Dividends per Share of ₹0.00 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Beta Drugs and its competitors.
Is Beta Drugs' Dividends per Share too high?
Beta Drugs' current Dividends per Share is ₹0.00. Overall, Beta Drugs has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Beta Drugs' Dividends per Share compare to ZTS and UTHR?
Beta Drugs' Dividends per Share of ₹0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Beta Drugs and its competitors. Beta Drugs's current Dividends per Share is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beta Drugs stock overvalued right now?
Based on GuruFocus' analysis, Beta Drugs (NSE:BETA) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,982.44, compared to a current price of ₹2,229.10 — trading 12.4% above its estimated fair value. The current Dividends per Share is ₹0.00. Beta Drugs' overall GF Score™ is 94/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Beta Drugs (NSE:BETA), the current Dividends per Share is ₹0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beta Drugs (NSE:BETA) Overvalued in 2026?

Based on GuruFocus' analysis, Beta Drugs stock appears to be overvalued. The current stock price of ₹2,229.10 is trading 12.4% above its estimated GF Value™ of ₹1,982.44. GuruFocus considers Beta Drugs to be Modestly Overvalued.

Key valuation signals for NSE:BETA:

  • Dividends per Share: ₹0.00
  • GF Value™: ₹1,982.44 vs. price of ₹2,229.10 (12.4% above fair value)
  • GF Score™: 94/100 with 7 warning signs

No single metric tells the full story. See the NSE:BETA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beta Drugs Business Description

Address SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114
Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports them to other countries, of which key revenue is derived from the sales made in India.
94GF Score

Get the complete analysis for NSE:BETA

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,229.10
Price
₹1,982.44
GF Value